These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27499043)

  • 1. Selection and characterization of the novel anti-human PD-1 FV78 antibody from a targeted epitope mammalian cell-displayed antibody library.
    Luo L; Wang S; Lang X; Zhou T; Geng J; Li X; Qiao C; Feng J; Shen B; Lv M; Li Y
    Cell Mol Immunol; 2018 Feb; 15(2):146-157. PubMed ID: 27499043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform.
    Gjetting T; Gad M; Fröhlich C; Lindsted T; Melander MC; Bhatia VK; Grandal MM; Dietrich N; Uhlenbrock F; Galler GR; Strandh M; Lantto J; Bouquin T; Horak ID; Kragh M; Pedersen MW; Koefoed K
    MAbs; 2019; 11(4):666-680. PubMed ID: 31046547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of a PD-1 blocking antibody from a novel fully human phage display library.
    Peissert F; Plüss L; Giudice AM; Ongaro T; Villa A; Elsayed A; Nadal L; Dakhel Plaza S; Scietti L; Puca E; De Luca R; Forneris F; Neri D
    Protein Sci; 2022 Dec; 31(12):e4486. PubMed ID: 36317676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare, high-affinity mouse anti-PD-1 antibodies that function in checkpoint blockade, discovered using microfluidics and molecular genomics.
    Adler AS; Mizrahi RA; Spindler MJ; Adams MS; Asensio MA; Edgar RC; Leong J; Leong R; Johnson DS
    MAbs; 2017; 9(8):1270-1281. PubMed ID: 28846506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the structural and energetic basis of PD-1 and monoclonal antibodies bound to PD-L1: A molecular modeling perspective.
    Shi D; Zhou S; Liu X; Zhao C; Liu H; Yao X
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):576-588. PubMed ID: 29203283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction of dengue virus-specific full-length fully human antibody libraries by mammalian display technology].
    Wen Y; Lan K; Wang J; Yu J; Qu Y; Zhao W; Zhang F; Tan W; Cao H; Zhou C
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):847-52. PubMed ID: 23803195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BLI-Based Functional Assay in Phage Display Benefits the Development of a PD-L1-Targeting Therapeutic Antibody.
    Choi JR; Kim MJ; Tae N; Wi TM; Kim SH; Lee ES; Kim DH
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32630442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity maturation of antiHER2 monoclonal antibody MIL5 using an epitope-specific synthetic phage library by computational design.
    Qiao C; Lv M; Li X; Geng J; Li Y; Zhang J; Lin Z; Feng J; Shen B
    J Biomol Struct Dyn; 2013; 31(5):511-21. PubMed ID: 23003339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid screening and production method using a novel mammalian cell display to isolate human monoclonal antibodies.
    Tomimatsu K; Matsumoto SE; Tanaka H; Yamashita M; Nakanishi H; Teruya K; Kazuno S; Kinjo T; Hamasaki T; Kusumoto K; Kabayama S; Katakura Y; Shirahata S
    Biochem Biophys Res Commun; 2013 Nov; 441(1):59-64. PubMed ID: 24140057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-L1 Detection in Tumors Using [(64)Cu]Atezolizumab with PET.
    Lesniak WG; Chatterjee S; Gabrielson M; Lisok A; Wharram B; Pomper MG; Nimmagadda S
    Bioconjug Chem; 2016 Sep; 27(9):2103-10. PubMed ID: 27458027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel synthetic naïve human antibody library allows the isolation of antibodies against a new epitope of oncofetal fibronectin.
    Villa A; Lovato V; Bujak E; Wulhfard S; Pasche N; Neri D
    MAbs; 2011; 3(3):264-72. PubMed ID: 21487243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unexpected N-terminal loop in PD-1 dominates binding by nivolumab.
    Tan S; Zhang H; Chai Y; Song H; Tong Z; Wang Q; Qi J; Wong G; Zhu X; Liu WJ; Gao S; Wang Z; Shi Y; Yang F; Gao GF; Yan J
    Nat Commun; 2017 Feb; 8():14369. PubMed ID: 28165004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine epitope mapping of monoclonal antibody 5F1 reveals anticatalytic activity toward the N domain of human angiotensin-converting enzyme.
    Danilov SM; Watermeyer JM; Balyasnikova IV; Gordon K; Kugaevskaya EV; Elisseeva YE; Albrecht RF; Sturrock ED
    Biochemistry; 2007 Aug; 46(31):9019-31. PubMed ID: 17630779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulators targeting the PD-1/PD-L1 protein-protein interaction: From antibodies to small molecules.
    Yang J; Hu L
    Med Res Rev; 2019 Jan; 39(1):265-301. PubMed ID: 30215856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PD1:PD-L1 interaction by an E. coli-derived optimized PD1 variant.
    Brand Shwartz M; Assor M; Dotan N; Ratzon E; Cohen E; Ruimi N; Bloch I; Gal M; Yadid I
    Biochem Biophys Res Commun; 2018 Nov; 506(3):731-738. PubMed ID: 30384998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of the efficacy, pharmacokinetics and immunogenicity of JS-001, a programmed cell death protein-1 (PD-1) monoclonal antibody.
    Fu J; Wang F; Dong LH; Zhang J; Deng CL; Wang XL; Xie XY; Zhang J; Deng RX; Zhang LB; Wu H; Feng H; Chen B; Song HF
    Acta Pharmacol Sin; 2017 May; 38(5):710-718. PubMed ID: 28317872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and In Vitro Functional Analyses of Novel Plant-Produced Anti-Human PD1 Antibody.
    Rattanapisit K; Phakham T; Buranapraditkun S; Siriwattananon K; Boonkrai C; Pisitkun T; Hirankarn N; Strasser R; Abe Y; Phoolcharoen W
    Sci Rep; 2019 Oct; 9(1):15205. PubMed ID: 31645587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Analytical Comparison of Dako 28-8 PharmDx Assay and an E1L3N Laboratory-Developed Test in the Immunohistochemical Detection of Programmed Death-Ligand 1.
    Cogswell J; Inzunza HD; Wu Q; Feder JN; Mintier G; Novotny J; Cardona DM
    Mol Diagn Ther; 2017 Feb; 21(1):85-93. PubMed ID: 27667773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8
    Zahm CD; Colluru VT; McNeel DG
    Cancer Immunol Res; 2017 Aug; 5(8):630-641. PubMed ID: 28634215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope-specific antibody response to IgE by mimotope immunization.
    Rudolf MP; Vogel M; Kricek F; Ruf C; Zürcher AW; Reuschel R; Auer M; Miescher S; Stadler BM
    J Immunol; 1998 Apr; 160(7):3315-21. PubMed ID: 9531289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.